Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology

Phase 1 Completed 50 enrolled University of Toronto

NaSingle-groupOpen-labelBasic science

Summary

A non-randomized, interventional, longitudinal clinical study to quantify the impact of bacterial vaginosis treatment on HIV susceptibility and genital immunology in Kenyan women.

Timeline

Start: 2015-08
Primary completion: 2015-11
Completion: 2015-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metronidazole	Small molecule	400 mg	Oral

Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology

Summary

Timeline

Drugs

Indications